CDY13P

Q-omics provides the consensus-scored CDY13P profile across patient tissues and cancer cell-line models. CDY13P expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in HNSC. Additionally, CDY13P RNA expression shows 51 significant gene co-expression associations, with the highest sampling consensus in LAML. Together, these results highlight HNSC, and LAML as cancer lineages where CDY13P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes CDY13P survival associations across molecular data types. CDY13P RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

CDY13P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	HNSC (108)	view →

This table ranks reproducible CDY13P RNA expression–survival associations across cancer types. High CDY13P expression shows unfavorable associations in HNSC. The HNSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .006). Together, the overview and detailed table identify HNSC as the clearest survival context for CDY13P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.181	0.687	.006	108	view →

Pink = unfavorable, green = favorable. all 1 lineages →

CDY13P-HNSC (OS)

Explore this curve interactively →